Pathologic stage III endometrial cancer treated with adjuvant radiation therapy

International Journal of Gynecological Cancer

Volumn 9, Issue 3, 1999, Pages 243-246

  Gerszten, K ^a   Faul, C ^a   Huang, Q ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Adjuvant radiation therapy; Stage III endometrial carcinoma

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADJUVANT THERAPY; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE;

EID: 0032969375     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.99028.x     Document Type: Article

References (15)

1. Aalders JG, Abeler V, Kolstad P. Clinical (Stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients. Gynecol Oncol 1984; 17: 64-74.
2. Grigsby PW, Perez CA, Kuske RR, Kao MS, Galakatos AE. Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium. Gynecol Oncol 1987; 27: 44-57.
3. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Sur g Pathol 1982; 6: 93-108.
4. Kadar N, Homesley HD, Malfetano JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 1992; 46: 145-9.
5. Mackillop WJ, Pringle JF. Stage III endometrial cancer: A review of 90 cases. Cancer 1985; 56: 2519-23.
6. Schorge J, Molpus KL, Goodman A, Nikrui N, Fuller AF. The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 1996; 63: 34-9.
7. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. Gynecol Oncol 1991; 40: 55-65.
8. Greven K, Lanciano RM, Corn B, Case D, Randall M. Pathologic stage III endometrial cancer: prognostic factors and patterns of recurrence. Cancer 1993; 71: 3697-702.
9. Takeshima N, Hirai Y, Yano K, Tanaka N, Yamauchi K, Hasumi K. Ovarian metastasis in endometrial carcinoma. Gynecol Oncol 1998; 27: 104-9.
10. Feuer GA, Clanog A. Endometrial carcinoma: Treatment of positive paraaortic nodes. Gynecol Oncol 1987; 27: 104-9.
11. Rose PG, Cha SD, Tak WK, Fitzgerald T, Reale F, Hunter RE. Radiation therapy for surgically proven para-aortic node metastases in endometrial carcinoma, Int J Radiat Oncol Biol Phys 1992; 24: 229-33.
12. Onda T, Yoshikawa H, Mizutani K et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 1997; 75: 1836-41.
13. Reisinger SA, Asbury R, Liao S-Y, Homesley HD. A phase I study of weekly cisplain and whole abdominal radiation for treatment of stage III and IV endometrial carcinoma: A gynecologic oncology group pilot study. Gynecol Oncol 1996; 63: 299-303.
14. Potish R, Twiggs L, Adcock L, Prem KA. Role of whole abdominal irradiation for tumors of the uterine corpus. Gynecol Oncol 1985; 21: 80-6.
15. Loeffler J, Rosen E, Niloff J, Howes A, Knapp R. Whole abdominal irradiation for tumors of the uterine corpus. Cancer 1988; 61: 1332-5.